Dolby Laboratories, Inc.
DLB
$67.48
$1.973.01%
NYSE
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.60% | 24.39% | 34.79% | 39.52% | 30.48% |
| Total Depreciation and Amortization | 12.91% | 12.85% | 5.44% | -2.71% | -8.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.06% | -1.23% | -21.73% | -13.28% | -14.26% |
| Change in Net Operating Assets | 85.67% | 95.36% | -175.88% | 62.77% | -182.66% |
| Cash from Operations | 44.29% | 57.22% | 5.85% | 33.38% | -10.85% |
| Capital Expenditure | -21.13% | 10.81% | 6.35% | -5.02% | 1.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.72% | -- | -2,003.43% | -2,003.43% | -1,998.13% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.58% | 1,899.88% | 2,594.79% | 648.11% | 293.58% |
| Cash from Investing | 96.30% | -459.31% | -1,584.30% | -1,211.82% | -628.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.77% | -22.38% | -34.49% | -21.11% | -14.35% |
| Repurchase of Common Stock | 18.38% | 28.25% | 27.21% | 40.18% | -10.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.49% | -10.58% | -10.79% | -10.83% | -10.80% |
| Other Financing Activities | 87.76% | -166.83% | -1,334.38% | -1,311.37% | -1,869.19% |
| Cash from Financing | 14.10% | 10.05% | 3.20% | 18.99% | -21.54% |
| Foreign Exchange rate Adjustments | -81.40% | 494.04% | 26.48% | -314.68% | 29.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.76% | -7.43% | -156.53% | -225.68% | -226.70% |